Schweizer W, Duda P, Tanner S, Balsiger D, Höflin F, Blumgart L H, Zimmermann A
Department of Visceral and Transplantation Surgery, University of Bern, Inselspital, Switzerland.
J Hepatol. 1995 Jul;23(1):71-8. doi: 10.1016/0168-8278(95)80313-0.
BACKGROUND/AIMS: Patients with lobar or segmental impairment of bile flow or of portal venous blood flow frequently develop considerable atrophy of the area involved, followed by compensatory hypertrophy/hyperplasia of the non-affected parts. This configuration is termed atrophy/hypertrophy complex of the liver.
In order to analyze the relative contributions of bile duct and portal vein obstruction in the pathogenesis of atrophy/hypertrophy complex, we developed a rat model with selective bile duct and/or portal vein ligation of the anterior liver lobes, representing about two thirds of the liver mass. Evolution of total body weights and weights of the different liver lobes were determined, and morphometry and functional scintigraphy (hepatoiodida scanning) were performed immediately after ligation and at 30 h, 4, 8 and 28 days postoperatively.
The major findings were: 28 days after biliary and/or portal ligation there was no difference between the body weights of all animals, all ligated animals having compensated an initial body weight loss. Total liver weight remained constant during the whole observation period, while atrophy of the anterior and hypertrophy/hyperplasia of the posterior lobes occurred. A significant atrophy/hypertrophy complex developed only after selective portal ligation, but not after selective biliary ligation. Morphometrically analyzed histologic changes after selective biliary ligation were reversible, whereas in portally ligated liver lobes a progressive parenchymal destruction and involution with subsequent impairment of hepatic function of the concerned lobe were observed.
The present findings indicate that impairment of portal venous flow is the major driving force for the development of lobar atrophy in the rat and that atrophy/hypertrophy complex can be produced in a rodent model.
背景/目的:肝叶或肝段胆汁流或门静脉血流受损的患者,其受累区域常出现明显萎缩,随后未受累部分发生代偿性肥大/增生。这种情况被称为肝脏萎缩/肥大复合体。
为分析胆管和门静脉梗阻在萎缩/肥大复合体发病机制中的相对作用,我们建立了一种大鼠模型,选择性结扎肝脏前叶的胆管和/或门静脉,肝脏前叶约占肝脏质量的三分之二。测定总体重和不同肝叶的重量变化,并在结扎后即刻以及术后30小时、4天、8天和28天进行形态学测量和功能性闪烁扫描(肝碘扫描)。
主要发现如下:胆管和/或门静脉结扎28天后,所有动物的体重无差异,所有结扎动物均已代偿了最初的体重减轻。在整个观察期内,肝脏总重量保持恒定,而前叶萎缩而后叶肥大/增生。仅在选择性门静脉结扎后出现明显的萎缩/肥大复合体,而选择性胆管结扎后未出现。选择性胆管结扎后经形态学分析的组织学变化是可逆的,而在门静脉结扎的肝叶中,观察到渐进性实质破坏和退化,随后相关肝叶的肝功能受损。
目前的研究结果表明,门静脉血流受损是大鼠肝叶萎缩发生的主要驱动力,并且在啮齿动物模型中可以产生萎缩/肥大复合体。